Why the study?
With an aging society increasing head trauma among elderly patients taking antithrombotic drugs and driving up reversal agent use, examining measures and accumulating data is needed to improve outcomes.
Does reversal therapy for antithrombotic drugs improve outcomes in older patients with traumatic brain injury?
Does reversal therapy for antithrombotic drugs improve outcomes in older patients with traumatic brain injury?
Early administration of reversal agents and early resumption of antithrombotics are recommended to balance the risks of secondary brain damage and ischemic complications in older patients with traumatic brain injury.
May support early reversal for anticoagulants in acute subdural hematoma; leaves open optimal strategies in older TBI patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eiichi Suehiro (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: